We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$804M
AUM Growth
+$62.4M
Cap. Flow
+$3.16M
Cap. Flow %
0.39%
Top 10 Hldgs %
27.6%
Holding
264
New
30
Increased
63
Reduced
144
Closed
15

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.84M
2
DELL icon
Dell
DELL
+$4.44M
3
MU icon
Micron Technology
MU
+$3.99M
4
IBM icon
IBM
IBM
+$2.52M
5
MDT icon
Medtronic
MDT
+$2.35M

Sector Composition

Rank Sector Weight
1 Technology 20.31%
2 Financials 11.52%
3 Healthcare 8.37%
4 Communication Services 6.65%
5 Industrials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
51
ASML
ASML
$695B
$5.45M 0.68%
+6,795
New +$4.88M
EMR icon
52
Emerson Electric
EMR
$91.4B
$5.42M 0.67%
40,626
-1,537
-4% -$176K
HON icon
53
Honeywell
HON
$74.6B
$5.41M 0.67%
24,668
-1,720
-7% -$348K
TEVA icon
54
Teva Pharmaceuticals
TEVA
$42.8B
$5.27M 0.66%
314,305
-62,726
-17% -$1.01M
DIS icon
55
Walt Disney
DIS
$178B
$5.23M 0.65%
42,139
-16,052
-28% -$1.67M
CEG icon
56
Constellation Energy
CEG
$98.7B
$5.14M 0.64%
15,916
-6,462
-29% -$1.71M
HBAN icon
57
Huntington Bancshares
HBAN
$36.1B
$4.81M 0.6%
287,046
-86,122
-23% -$1.3M
QQQ icon
58
Invesco QQQ Trust
QQQ
$481B
$4.69M 0.58%
8,501
-213
-2% -$106K
MCD icon
59
McDonald's
MCD
$195B
$4.65M 0.58%
15,901
-187
-1% -$57.7K
TT icon
60
Trane Technologies
TT
$105B
$4.59M 0.57%
10,487
-3,138
-23% -$1.24M
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$133B
$4.58M 0.57%
10,298
-1,595
-13% -$735K
MCHI icon
62
iShares MSCI China ETF
MCHI
$6.21B
$4.51M 0.56%
81,791
+3,977
+5% +$211K
ACN icon
63
Accenture
ACN
$110B
$4.3M 0.54%
14,401
-3,822
-21% -$1.16M
PFF icon
64
iShares Preferred and Income Securities ETF
PFF
$13.3B
$4.15M 0.52%
135,277
+489
+0.4% +$14.7K
APO icon
65
Apollo Global Management
APO
$81.9B
$4.13M 0.51%
29,078
+2,984
+11% +$396K
AMGN icon
66
Amgen
AMGN
$225B
$4.07M 0.51%
14,583
-5,673
-28% -$1.61M
NVO
67
Novo Nordisk
NVO
$203B
$3.93M 0.49%
+56,884
New +$3.87M
J icon
68
Jacobs Solutions
J
$17B
$3.92M 0.49%
29,858
-7,953
-21% -$981K
MSI icon
69
Motorola Solutions
MSI
$77.7B
$3.87M 0.48%
9,205
+4,668
+103% +$1.95M
FANG icon
70
Diamondback Energy
FANG
$56.2B
$3.85M 0.48%
28,020
-998
-3% -$138K
VMBS icon
71
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$3.82M 0.48%
82,424
+2,060
+3% +$94.3K
BBCA icon
72
JPMorgan BetaBuilders Canada ETF
BBCA
$11.3B
$3.76M 0.47%
46,578
+1,045
+2% +$79.2K
CB icon
73
Chubb
CB
$132B
$3.67M 0.46%
12,672
-238
-2% -$68.5K
ADP icon
74
Automatic Data Processing
ADP
$107B
$3.65M 0.45%
11,847
-18
-0.2% -$5.53K
BIDU icon
75
Baidu
BIDU
$35.6B
$3.34M 0.42%
38,976
+10,501
+37% +$906K

Similar funds

Greenwood Capital Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Greenwood Capital Associates held 264 positions worth $804M, up 8.4% from $741M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Greenwood Capital Associates's Q2 2025 filing shows 30 new, 63 increased, 144 reduced and 15 closed positions. Its largest new stake was ASML: 6,795 shares worth $5.45M. The largest sale was Merck, an estimated $6.84M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Greenwood Capital Associates's largest Q2 2025 buy was ASML: 6,795 shares worth $5.45M.
  • Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $14.3M increase.
  • Greenwood Capital Associates's biggest Q2 2025 reduction was IBM, cutting an estimated $2.52M.
  • Greenwood Capital Associates fully exited Merck in Q2 2025, selling an estimated $6.84M.
  • Greenwood Capital Associates's ten largest holdings make up 28% of its $804M portfolio in Q2 2025.
  • Greenwood Capital Associates opened 30 new positions and closed 15 in Q2 2025.
  • Greenwood Capital Associates's portfolio value rose 8.4% quarter-over-quarter to $804M.

Based on Greenwood Capital Associates's 13F filing for Q2 2025, filed 21 Jul 2025.